Fri, Dec 26, 2014, 9:29 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • robbie1165 robbie1165 Jun 30, 2013 2:59 PM Flag

    Pfizer buyout still part of the buzz!

    From the latest Motley Fool article on Pfizer:
    Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a "broad array of strategic alternatives."

    The Elelyso connection does appear to make Protalix a reasonable fit for Pfizer. Israeli newspaper Calcalist reported in February that Protalix wanted to sell for $1 billion. That's more than twice the current market cap of the company and could be more than what larger players are willing to pay. However, that price tag is only a drop in the bucket for Pfizer

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
PLX
1.83-0.02(-1.08%)Dec 26 4:02 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
TASER International Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
The GEO Group, Inc.
NYSEFri, Dec 26, 2014 4:03 PM EST